Altavo
PrivateLast Round
Series A
Extension
Jan 12, 2026
Total Funding Raised
$8.92M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Altavo is a medical device company developing an artificial voice to help voiceless people regain a natural-sounding voice using non-invasive radar sensing and artificial intelligence.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, NLP & Conversational AI, Sensors
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Altavo Comparables
Compare Altavo with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Laronix | 86% | |
| Andreas Fahl Medizintechnik-Vertrieb GmbH | 74% | |
| Coloplast | 72% |
Altavo Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jan 12, 2026 | ||||
| Series A | Feb 1, 2024 | ||||
| Seed | Dec 22, 2021 |
Key People
Founding team and executive leadership
Altavo Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ostwerk GmbH | Series A Extension |
| CFH Management | Seed |
| TGFS Technologiegründerfonds Sachsen | Series A Extension |
| TGFS Technologiegründerfonds Sachsen | Series A Extension, Series A |
| bm|t beteiligungsmanagement thüringen | Series A, Series A Extension |
| High-Tech Gründerfonds | Series A Extension |
| Novalis Biotech | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 12, 2026
Raised $3.5M in a Series A Extension round.
- Feb 1, 2024
$5.4M round led by OCCIDENT
Altavo Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Altavo's valuation, stock price, and market status.
Is Altavo a public or private company?
Altavo is a private company.
What is the current stock price of Altavo?
Altavo is a private company with no public stock price. Caplight tracks Altavo's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Altavo worth (valuation)?
Valuation information for Altavo is not publicly available.
Can I buy Altavo stock?
Altavo shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Altavo's last funding round?
Altavo's most recent funding round was Series A Extension on January 12, 2026.
Who are the main investors in Altavo?
Key investors in Altavo include bm|t beteiligungsmanagement thüringen, Novalis Biotech, OCCIDENT.
Will Altavo IPO soon?
No public IPO plans have been announced for Altavo.
How can I track Altavo secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Altavo's secondary market activity and sign up for updates.